![](/img/cover-not-exists.png)
Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors
Wei, Zhigang, An, Tongtong, Wang, Zhijie, Chen, Keneng, Bai, Hua, Zhu, Guangying, Duan, Jianchun, Wu, Meina, Yang, Lu, Zhuo, Minglei, Wang, Yuyan, Liu, Xuyi, Wang, JieVolume:
5
Language:
english
Journal:
Thoracic Cancer
DOI:
10.1111/1759-7714.12068
Date:
March, 2014
File:
PDF, 874 KB
english, 2014